CA - Acasti Pharma GAAP EPS of -$0.54 August, 11 2023 07:42 AM CA Inc. 2023-08-11 07:42:52 ET Acasti Pharma press release ( NASDAQ: ACST ): Q2 GAAP EPS of -$0.54. Cash and cash equivalents as of quarter end were $21.6 million; company reiterates projected cash runway to Q2 2025 For further details see: Acasti Pharma GAAP EPS of -$0.54